These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 26459897)

  • 1. Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
    Lee JY; Choi MJ; Choi HJ; Ko KS
    Antimicrob Agents Chemother; 2016 Jan; 60(1):609-12. PubMed ID: 26459897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Modification of Lipopolysaccharide Conferred by
    Liu YY; Chandler CE; Leung LM; McElheny CL; Mettus RT; Shanks RMQ; Liu JH; Goodlett DR; Ernst RK; Doi Y
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373195
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates.
    Choi MJ; Park YK; Peck KR; Ko KS
    Int J Antimicrob Agents; 2014 Nov; 44(5):475-6. PubMed ID: 25443890
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
    Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
    Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to polymyxins in Gram-negative organisms.
    Jeannot K; Bolard A; Plésiat P
    Int J Antimicrob Agents; 2017 May; 49(5):526-535. PubMed ID: 28163137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.
    Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli.
    Ayerbe-Algaba R; Gil-Marqués ML; Miró-Canturri A; Parra-Millán R; Pachón-Ibáñez ME; Jiménez-Mejías ME; Pachón J; Smani Y
    Int J Antimicrob Agents; 2019 Oct; 54(4):507-512. PubMed ID: 31299296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study.
    Tellapragada C; Hasan B; Antonelli A; Maruri A; de Vogel C; Gijón D; Coppi M; Verbon A; van Wamel W; Rossolini GM; Cantón R; Giske CG
    Clin Microbiol Infect; 2020 Oct; 26(10):1413.e1-1413.e7. PubMed ID: 32006694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.
    Choi MJ; Ko KS
    J Antimicrob Chemother; 2014 Jan; 69(1):275-7. PubMed ID: 23997018
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study.
    Matthaiou DK; Michalopoulos A; Rafailidis PI; Karageorgopoulos DE; Papaioannou V; Ntani G; Samonis G; Falagas ME
    Crit Care Med; 2008 Mar; 36(3):807-11. PubMed ID: 18431267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
    Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
    Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece.
    Samonis G; Matthaiou DK; Kofteridis D; Maraki S; Falagas ME
    Clin Infect Dis; 2010 Jun; 50(12):1689-91. PubMed ID: 20482269
    [No Abstract]   [Full Text] [Related]  

  • 13. An Improved Medium for Colistin Susceptibility Testing.
    Gwozdzinski K; Azarderakhsh S; Imirzalioglu C; Falgenhauer L; Chakraborty T
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29514937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
    Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
    Hamouche E; Sarkis DK
    Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of mcr family of colistin resistance genes in Gram-negative isolates from a tertiary care hospital in India.
    Irusan D; Akshay SD; Shetty VP; Karunasagar I; Deekshit VK; Rohit A
    J Appl Microbiol; 2024 Jul; 135(7):. PubMed ID: 38986507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of multiple carbapenemase-producing Gram-negative species, colistin-resistant KPC-2-producing Klebsiella pneumoniae ST11, IMP-7-producing Pseudomonas aeruginosa ST357, and OXA-23-producing Acinetobacter baumannii ST1050, in a single patient.
    Nishida S; Ishigaki S; Asahara M; Furukawa T; Ono Y
    Int J Antimicrob Agents; 2018 Oct; 52(4):512-514. PubMed ID: 30318057
    [No Abstract]   [Full Text] [Related]  

  • 18. An Amphipathic Undecapeptide with All d-Amino Acids Shows Promising Activity against Colistin-Resistant Strains of Acinetobacter baumannii and a Dual Mode of Action.
    Oddo A; Thomsen TT; Kjelstrup S; Gorey C; Franzyk H; Frimodt-Møller N; Løbner-Olesen A; Hansen PR
    Antimicrob Agents Chemother; 2016 Jan; 60(1):592-9. PubMed ID: 26574005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program.
    Al Rahmany D; Albeloushi A; Alreesi I; Alzaabi A; Alreesi M; Pontiggia L; Ghazi IM
    Int J Infect Dis; 2019 Jun; 83():77-82. PubMed ID: 30959249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
    Vidaillac C; Benichou L; Duval RE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4856-61. PubMed ID: 22751540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.